Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea

A randomized placebo-controlled study

Wayne A. Bardwell, Daniel Norman, Sonia Ancoli-Israel, Jose S. Loredo, Amy Elizabeth Allison, Weonjeong Lim, Joel E. Dimsdale

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Psychological symptom improvement has been observed after continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA). Because CPAP normalizes both sleep disruption and oxyhemoglobin desaturation, the mechanism of psychological symptom improvement is unclear. Using a 3-arm placebo-controlled design, we parsed out the separate effects of treatment on psychological symptoms. OSA patients (N = 38) were monitored 2 nights with polysomnography and then randomized to 2-weeks therapeutic CPAP, placebo CPAP, or O2 supplementation. Preand post-treatment, patients completed the Brief Symptom Inventory (BSI): Higher scores indicate greater severity. Repeated measures analysis of covariance reveals a Time × Treatment interaction for BSI Global Severity Index (GSI): significant pre- to post-treatment reductions in GSI with O2 supplementation and therapeutic CPAP, but not placebo CPAP. A Time × Treatment interaction was also found for depression: Depression decreased with O2 supplementation but not with therapeutic CPAP or placebo CPAP. Both therapeutic CPAP and O2 supplementation resulted in decreased psychological symptoms. Results suggest hypoxemia may play a stronger role than sleep disruption vis-à-vis OSA related psychological distress.

Original languageEnglish (US)
Pages (from-to)21-38
Number of pages18
JournalBehavioral Sleep Medicine
Volume5
Issue number1
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Obstructive Sleep Apnea
Placebos
Psychology
Oxygen
Therapeutics
Sleep
Depression
Equipment and Supplies
Oxyhemoglobins
Polysomnography

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Medicine (miscellaneous)
  • Psychology (miscellaneous)
  • Clinical Neurology

Cite this

Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea : A randomized placebo-controlled study. / Bardwell, Wayne A.; Norman, Daniel; Ancoli-Israel, Sonia; Loredo, Jose S.; Allison, Amy Elizabeth; Lim, Weonjeong; Dimsdale, Joel E.

In: Behavioral Sleep Medicine, Vol. 5, No. 1, 01.12.2007, p. 21-38.

Research output: Contribution to journalArticle

@article{15224af3b90c49478ce937012929accb,
title = "Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: A randomized placebo-controlled study",
abstract = "Psychological symptom improvement has been observed after continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA). Because CPAP normalizes both sleep disruption and oxyhemoglobin desaturation, the mechanism of psychological symptom improvement is unclear. Using a 3-arm placebo-controlled design, we parsed out the separate effects of treatment on psychological symptoms. OSA patients (N = 38) were monitored 2 nights with polysomnography and then randomized to 2-weeks therapeutic CPAP, placebo CPAP, or O2 supplementation. Preand post-treatment, patients completed the Brief Symptom Inventory (BSI): Higher scores indicate greater severity. Repeated measures analysis of covariance reveals a Time × Treatment interaction for BSI Global Severity Index (GSI): significant pre- to post-treatment reductions in GSI with O2 supplementation and therapeutic CPAP, but not placebo CPAP. A Time × Treatment interaction was also found for depression: Depression decreased with O2 supplementation but not with therapeutic CPAP or placebo CPAP. Both therapeutic CPAP and O2 supplementation resulted in decreased psychological symptoms. Results suggest hypoxemia may play a stronger role than sleep disruption vis-{\`a}-vis OSA related psychological distress.",
author = "Bardwell, {Wayne A.} and Daniel Norman and Sonia Ancoli-Israel and Loredo, {Jose S.} and Allison, {Amy Elizabeth} and Weonjeong Lim and Dimsdale, {Joel E.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1207/s15402010bsm0501_2",
language = "English (US)",
volume = "5",
pages = "21--38",
journal = "Behavioral Sleep Medicine",
issn = "1540-2002",
publisher = "Routledge",
number = "1",

}

TY - JOUR

T1 - Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea

T2 - A randomized placebo-controlled study

AU - Bardwell, Wayne A.

AU - Norman, Daniel

AU - Ancoli-Israel, Sonia

AU - Loredo, Jose S.

AU - Allison, Amy Elizabeth

AU - Lim, Weonjeong

AU - Dimsdale, Joel E.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Psychological symptom improvement has been observed after continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA). Because CPAP normalizes both sleep disruption and oxyhemoglobin desaturation, the mechanism of psychological symptom improvement is unclear. Using a 3-arm placebo-controlled design, we parsed out the separate effects of treatment on psychological symptoms. OSA patients (N = 38) were monitored 2 nights with polysomnography and then randomized to 2-weeks therapeutic CPAP, placebo CPAP, or O2 supplementation. Preand post-treatment, patients completed the Brief Symptom Inventory (BSI): Higher scores indicate greater severity. Repeated measures analysis of covariance reveals a Time × Treatment interaction for BSI Global Severity Index (GSI): significant pre- to post-treatment reductions in GSI with O2 supplementation and therapeutic CPAP, but not placebo CPAP. A Time × Treatment interaction was also found for depression: Depression decreased with O2 supplementation but not with therapeutic CPAP or placebo CPAP. Both therapeutic CPAP and O2 supplementation resulted in decreased psychological symptoms. Results suggest hypoxemia may play a stronger role than sleep disruption vis-à-vis OSA related psychological distress.

AB - Psychological symptom improvement has been observed after continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA). Because CPAP normalizes both sleep disruption and oxyhemoglobin desaturation, the mechanism of psychological symptom improvement is unclear. Using a 3-arm placebo-controlled design, we parsed out the separate effects of treatment on psychological symptoms. OSA patients (N = 38) were monitored 2 nights with polysomnography and then randomized to 2-weeks therapeutic CPAP, placebo CPAP, or O2 supplementation. Preand post-treatment, patients completed the Brief Symptom Inventory (BSI): Higher scores indicate greater severity. Repeated measures analysis of covariance reveals a Time × Treatment interaction for BSI Global Severity Index (GSI): significant pre- to post-treatment reductions in GSI with O2 supplementation and therapeutic CPAP, but not placebo CPAP. A Time × Treatment interaction was also found for depression: Depression decreased with O2 supplementation but not with therapeutic CPAP or placebo CPAP. Both therapeutic CPAP and O2 supplementation resulted in decreased psychological symptoms. Results suggest hypoxemia may play a stronger role than sleep disruption vis-à-vis OSA related psychological distress.

UR - http://www.scopus.com/inward/record.url?scp=34047251835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047251835&partnerID=8YFLogxK

U2 - 10.1207/s15402010bsm0501_2

DO - 10.1207/s15402010bsm0501_2

M3 - Article

VL - 5

SP - 21

EP - 38

JO - Behavioral Sleep Medicine

JF - Behavioral Sleep Medicine

SN - 1540-2002

IS - 1

ER -